Stock research on global mid-cap companies

Evaluate Research

Evaluate Research provides institutional quality stock research on small-cap and  mid-cap companies on a global basis, thus helping connect investors with the company.

At Evaluate Research, we provide free of cost to all investors a 20-25 page Initiation Report which evaluates in great detail all aspects of the company:  growth opportunities, catalysts, business description, competitive positioning, SWOT analysis, risks, etc.  In addition, we determine specific price targets for the company based on detailed 5-year complete forecasts of financial statements including IS, BS, CF, ratios, etc.  Finally, whereas many sell-side brokers offer sketchy and irregular ongoing maintenance research of companies, if not outright dropped or termination of coverage, at Evaluate Research we systematically monitor and regularly publish Update Notes covering quarterly earnings, major corporate events, etc.

All of the research reports are broadly and freely disseminated globally to leading Fund Managers and analysts who invest specifically in mid-size equities, and also on leading investment information platforms including: Bloomberg, Thomson Reuters, FactSet etc.

Stock research on global mid-cap companies, Evaluate Research

Equity Bottom-Up

<p>Haw Par reported mixed Q2 [ended June] FY16 results where the revenue was broadly in-line with our estimates but the bottom-line fell short by 34%. For the reported quarter, the company posted SG$ 52.6 million in revenues, up 2.8% YoY, driven by growth in revenue from the Property and Leisure segments. However, operating income fell 18.7% YoY to SG$ 51 million mainly due to a 26% decline in other income [which includes lower dividend and investment income from the group’s equity investments].</p>
<p>Net profit decreased by 58.3% to SG$ 48.4 million as compared with the same period last year mainly due to weak dividend income and large one-time gain reported in last year’s Q2FY15 from partial disposal and reclassification of Hua Han Health Industry Holdings Ltd. [previously an associate company of Haw Par]. EPS came at SG$ 0.22 against SG$ 0.53 in the prior year quarter.</p>

Haw Par reported mixed Q2 [ended June] FY16 results where the revenue was broadly in-line with our estimates but the bottom-line fell short by 34%. For the reported quarter, the company posted SG$ 52.6 million in revenues, up 2.8% YoY, driven by growth in revenue from the Property and Leisure segments. However, operating income fell 18.7% YoY to SG$ 51 million mainly due to a 26% decline in other income [which includes lower dividend and investment income from the group’s equity investments].
Net profit decreased by 58.3% to SG$ 48.4 million as compared with the same period last year mainly due to weak dividend income and large one-time gain reported in last year’s Q2FY15 from partial disposal and reclassification of Hua Han Health Industry Holdings Ltd. [previously an associate company of Haw Par]. EPS came at SG$ 0.22 against SG$ 0.53 in the prior year quarter.

Haw Par Corp

Haw Par Corp: 2QFY2016 Earnings Update